Advertisement
CBOE or CME or ICE
Which Stock Would AI Choose? Cboe Global Markets (CBOE) vs. CME Group (CME) vs. Intercontinental Exchange (ICE) Stock Comparison
Key Takeaways
- Cboe Global Markets (CBOE) delivered the fastest recent revenue and earnings growth, driven by record options volume, but carries a narrower business footprint.
- CME Group (CME) posted a fourth consecutive year of record revenue and remains the dominant, most diversified derivatives marketplace.
- Intercontinental Exchange (ICE) offers the broadest revenue mix, spanning exchanges, fixed-income data, and mortgage technology, with the largest total revenue base.
- All three are highly profitable "picks-and-shovels" exchange operators that tend to benefit from market volatility and elevated trading activity.
- Relative performance and valuation sensitivity differ meaningfully: CBOE has shown stronger recent momentum, while ICE's diversification and CME's scale carry distinct risk profiles.
Introduction
Exchange operators have become a focal point for traders and investors evaluating how market volatility translates into recurring revenue. Cboe Global Markets, CME Group, and Intercontinental Exchange are three of the world's most important market-infrastructure companies, yet each monetizes trading activity in a different way. CBOE is anchored by options and derivatives, CME dominates futures and clearing, and ICE pairs exchanges with data services and mortgage technology. This stock comparison examines their recent performance, business models, and market positioning to help investors assess which profile best fits the current environment.
CBOE Overview and Recent Performance
CBOE (Cboe Global Markets) is best known for its options exchanges, including the proprietary index options that anchor its derivatives franchise, alongside North American and European equities, global foreign exchange, and futures. In recent weeks the company has reported record results, with fourth-quarter net revenue up roughly 28% year over year and adjusted diluted earnings per share (EPS) up about 46%, driven by a surge in options average daily volume. Full-year net revenue rose about 17%.
Sentiment has been supported by broad-based growth across derivatives, cash and spot markets, and its data business, as well as product innovation such as near-24-hour trading in Russell 2000 options. Management has also undertaken a strategic realignment, selling its Australia and Canada businesses and exiting corporate listings to focus on core strengths. The stock has outpaced the broader market in recent market activity, though its reliance on key index partnerships and a relatively concentrated options mix remain notable considerations.
CME Overview and Recent Performance
CME (CME Group) operates the world's leading derivatives marketplace, offering futures and options across interest rates, equity indexes, foreign exchange, energy, agriculture, and metals, alongside fixed-income and FX platforms BrokerTec and EBS. In recent weeks the company reported its fourth consecutive year of record annual revenue of roughly $6.5 billion, up about 6%, with record average daily volume of 28.1 million contracts for 2025.
Quarterly revenue rose about 8% and adjusted EPS increased nearly 10%, helped by record fourth-quarter volume and a 13% rise in full-year market-data revenue. Management has emphasized growth initiatives such as U.S. Treasury clearing, 24/7 cryptocurrency trading, and prediction markets. The company returned roughly $3.9 billion to shareholders in dividends during 2025 and maintains a strong cash position. Recent stock performance has been steady, with shares advancing in the weeks following its earnings release, reflecting solid execution and a durable, scale-driven business model.
ICE Overview and Recent Performance
ICE (Intercontinental Exchange) owns the New York Stock Exchange and operates global exchanges, clearing houses, and data businesses across energy, interest rates, and equities, alongside a fixed-income and data-services segment and a mortgage-technology unit built around the Black Knight acquisition. In recent weeks the company reported full-year 2025 revenue of about $9.9 billion, up 7%, with adjusted EPS up roughly 14%.
Fourth-quarter net revenue reached about $2.5 billion, with the exchange segment growing roughly 10% on strength in global oil and natural gas markets. Its index franchise ended the year with a record $794 billion in exchange-traded fund (ETF) assets under management tracking ICE indices. The mortgage-technology segment posted its strongest quarter since 2022 on higher refinancing activity. The company raised its dividend and returned $2.4 billion to shareholders in 2025. Relative to its peers, ICE's diversified model offers balance, though mortgage-technology renewal headwinds remain a near-term watch item.
Trending AI Robots
For traders seeking a systematic, data-driven edge across names like these, Tickeron's Trending AI Robots page offers a curated view of its marketplace of AI trading bots. Tickeron hosts hundreds of AI Trading Bots that collectively trade thousands of different tickers, but only the strongest performers most suited to current market conditions earn a place in this curated section. Each bot has a distinct trading style, strategy, timeframe, performance record, statistical profile, and set of tickers it trades, allowing users to match an approach to their own objectives and risk tolerance. Exploring the Trending AI Robots section can help investors compare how different automated strategies are currently positioning across the market.
Head-to-Head Comparison
While all three companies operate exchanges, their business models create distinct trade-offs. CBOE is the most options-centric, giving it higher sensitivity to equity-market volatility and the fastest recent growth, but also greater concentration risk. CME is the deepest in futures and clearing, with dominant positions in interest rates and commodities that provide steady, scalable revenue but somewhat slower growth than CBOE's derivatives surge. ICE is the most diversified, combining exchanges with recurring data and mortgage-technology revenue, which reduces reliance on any single trading cycle but introduces exposure to the housing market and integration execution.
On valuation sensitivity, CBOE and CME tend to command premium multiples tied to their high-margin transaction businesses, while ICE's broader mix produces a lower overall margin but steadier recurring revenue. Risk factors also differ: CBOE depends on key index partnerships, CME is exposed to interest-rate and rate-cycle dynamics, and ICE faces mortgage-technology renewal headwinds. In terms of recent momentum, CBOE has shown the strongest relative share-price performance, while CME and ICE have advanced more moderately. Growth drivers include CBOE's 0DTE (zero-days-to-expiration) and extended-hours options expansion, CME's Treasury clearing and crypto initiatives, and ICE's data, tokenization, and mortgage-automation efforts.
Tickeron AI Verdict
Based on observable factors, Tickeron's AI would likely lean toward Cboe Global Markets (CBOE) in the current environment. Its trend consistency and relative momentum are the strongest of the three, supported by accelerating volume growth, record results, and a focused strategic realignment. The AI framework would, however, weigh this against CBOE's greater concentration risk and richer valuation. CME and ICE offer stronger diversification and stability, with ICE's recurring revenue and CME's clearing scale providing defensive qualities. A probabilistic reading favors CBOE for trend and catalyst strength, while acknowledging that a shift toward lower volatility could narrow its edge relative to its more diversified peers.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CBOE sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for CBOE moved above the 200-day moving average on October 21, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on CBOE as a result. In 58 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
The Moving Average Convergence Divergence (MACD) for CBOE just turned positive on October 01, 2026. Looking at past instances where CBOE's MACD turned positive, the stock continued to rise in 34 of 54 cases over the following month. The odds of a continued upward trend are 63%.
CBOE moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CBOE crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 74%.
Following a +4.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBOE advanced for three days, in 197 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBOE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.
CBOE broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CBOE entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 14 (best 1 - 100 worst), indicating outstanding price growth. CBOE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 28 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.918) is normal, around the industry mean (4.019). P/E Ratio (24.772) is within average values for comparable stocks, (17.786). Projected Growth (PEG Ratio) (2.241) is also within normal values, averaging (1.780). Dividend Yield (0.011) settles around the average of (0.019) among similar stocks. P/S Ratio (5.615) is also within normal values, averaging (7.166).
CME in upward trend: 10-day moving average broke above 50-day moving average on October 14, 2026
The 10-day moving average for CME crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CME as a result. In 57 of 106 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for CME just turned positive on October 08, 2026. Looking at past instances where CME's MACD turned positive, the stock continued to rise in 22 of 47 cases over the following month. The odds of a continued upward trend are 47%.
CME moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where CME advanced for three days, in 170 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.
CME broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CME entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 23 (best 1 - 100 worst), indicating outstanding price growth. CME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.149) is normal, around the industry mean (4.019). P/E Ratio (25.821) is within average values for comparable stocks, (17.786). CME's Projected Growth (PEG Ratio) (4.578) is very high in comparison to the industry average of (1.780). Dividend Yield (0.017) settles around the average of (0.019) among similar stocks. CME's P/S Ratio (14.535) is slightly higher than the industry average of (7.166).
ICE in upward trend: 10-day moving average crossed above 50-day moving average on October 19, 2026
The 10-day moving average for ICE crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on ICE as a result. In 33 of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 47%.
The Moving Average Convergence Divergence (MACD) for ICE just turned positive on October 09, 2026. Looking at past instances where ICE's MACD turned positive, the stock continued to rise in 21 of 44 cases over the following month. The odds of a continued upward trend are 48%.
ICE moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICE advanced for three days, in 183 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 53%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
ICE broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ICE entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ICE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.996) is normal, around the industry mean (4.019). P/E Ratio (22.179) is within average values for comparable stocks, (17.786). Projected Growth (PEG Ratio) (2.071) is also within normal values, averaging (1.780). Dividend Yield (0.013) settles around the average of (0.019) among similar stocks. P/S Ratio (6.553) is also within normal values, averaging (7.166).
CBOE | CME | ICE | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 44 | 41 | 27 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 88 Overvalued | 97 Overvalued | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 28 | 34 | 53 | |
SMR RATING 1..100 | 37 | 54 | 59 | |
PRICE GROWTH RATING 1..100 | 14 | 23 | 34 | |
P/E GROWTH RATING 1..100 | 55 | 41 | 73 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ICE's Valuation (85) in the Investment Banks Or Brokers industry is in the same range as CBOE (88) and is in the same range as CME (97). This means that ICE's stock grew similarly to CBOE’s and similarly to CME’s over the last 12 months.
CBOE's Profit vs Risk Rating (28) in the Investment Banks Or Brokers industry is in the same range as CME (34) and is in the same range as ICE (53). This means that CBOE's stock grew similarly to CME’s and similarly to ICE’s over the last 12 months.
CBOE's SMR Rating (37) in the Investment Banks Or Brokers industry is in the same range as CME (54) and is in the same range as ICE (59). This means that CBOE's stock grew similarly to CME’s and similarly to ICE’s over the last 12 months.
CBOE's Price Growth Rating (14) in the Investment Banks Or Brokers industry is in the same range as CME (23) and is in the same range as ICE (34). This means that CBOE's stock grew similarly to CME’s and similarly to ICE’s over the last 12 months.
CME's P/E Growth Rating (41) in the Investment Banks Or Brokers industry is in the same range as CBOE (55) and is in the same range as ICE (73). This means that CME's stock grew similarly to CBOE’s and similarly to ICE’s over the last 12 months.
| CBOE | CME | ICE | |
|---|---|---|---|
| RSI ODDS (%) | 1 day ago 50% | 1 day ago 48% | N/A |
| Stochastic ODDS (%) | 1 day ago 46% | 1 day ago 46% | 1 day ago 39% |
| Momentum ODDS (%) | 1 day ago 60% | 1 day ago 54% | 1 day ago 47% |
| MACD ODDS (%) | 1 day ago 63% | 1 day ago 47% | 1 day ago 48% |
| TrendWeek ODDS (%) | 1 day ago 62% | 1 day ago 52% | 1 day ago 51% |
| TrendMonth ODDS (%) | 1 day ago 61% | 1 day ago 53% | 1 day ago 48% |
| Advances ODDS (%) | 1 day ago 61% | 1 day ago 50% | 7 days ago 53% |
| Declines ODDS (%) | 10 days ago 41% | 23 days ago 41% | 9 days ago 54% |
| BollingerBands ODDS (%) | 1 day ago 47% | 1 day ago 51% | 1 day ago 38% |
| Aroon ODDS (%) | 1 day ago 38% | 1 day ago 34% | 1 day ago 56% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CBOE’s FA Score shows that 2 FA rating(s) are green while CME’s FA Score has 1 green FA rating(s), and ICE’s FA Score reflects 1 green FA rating(s).
- CBOE’s FA Score: 2 green, 3 red.
- CME’s FA Score: 1 green, 4 red.
- ICE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CBOE’s TA Score shows that 6 TA indicator(s) are bullish while CME’s TA Score has 5 bullish TA indicator(s), and ICE’s TA Score reflects 5 bullish TA indicator(s).
- CBOE’s TA Score: 6 bullish, 5 bearish.
- CME’s TA Score: 5 bullish, 5 bearish.
- ICE’s TA Score: 5 bullish, 4 bearish.
Price Growth
CBOE (@Financial Publishing/Services) experienced а +6.11% price change this week, while CME (@Financial Publishing/Services) price change was +3.57% , and ICE (@Financial Publishing/Services) price fluctuated +1.66% for the same time period.
The average weekly price growth across all stocks in the @Financial Publishing/Services industry was +2.74%. For the same industry, the average monthly price growth was +6.15%, and the average quarterly price growth was +8.53%.
Reported Earning Dates
CBOE is expected to report earnings on Oct 30, 2026.
CME is expected to report earnings on Feb 10, 2027.
ICE is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Financial Publishing/Services (+2.74% weekly)The financial publishing /services sector includes companies that provide informational products and services that are of value to investors, financial/analytics professionals and other interested readers. The products include real-time stock quotes, financial news and analyses. Think S&P Global, Inc., Moody`s Corporation, Thomson-Reuters Corp and IHS Markit Ltd. Information is critical in making financial or investment decisions, and what makes this industry’s output relevant at all times, across various economic conditions.
Advertisement
CBOE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CBOE has been loosely correlated with CME. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CBOE jumps, then CME could also see price increases.
| Ticker / NAME | Correlation To CBOE | 1D Price Change % | ||
|---|---|---|---|---|
| CBOE | 100% | +2.79% | ||
| CME - CBOE | 61% Loosely correlated | +3.45% | ||
| MKTX - CBOE | 29% Poorly correlated | +0.24% | ||
| TW - CBOE | 29% Poorly correlated | +1.57% | ||
| ICE - CBOE | 28% Poorly correlated | +3.90% | ||
| ARBK - CBOE | 22% Poorly correlated | -4.91% | ||
More | ||||
CME and
Correlation & Price change
A.I.dvisor indicates that over the last year, CME has been loosely correlated with ICE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CME jumps, then ICE could also see price increases.
| Ticker / NAME | Correlation To CME | 1D Price Change % | ||
|---|---|---|---|---|
| CME | 100% | +3.45% | ||
| ICE - CME | 49% Loosely correlated | +3.90% | ||
| TW - CME | 45% Loosely correlated | +1.57% | ||
| NDAQ - CME | 36% Loosely correlated | +7.47% | ||
| MKTX - CME | 35% Loosely correlated | +0.24% | ||
| MSCI - CME | 26% Poorly correlated | +2.61% | ||
More | ||||
ICE and
Correlation & Price change
A.I.dvisor indicates that over the last year, ICE has been loosely correlated with SPGI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ICE jumps, then SPGI could also see price increases.
| Ticker / NAME | Correlation To ICE | 1D Price Change % | ||
|---|---|---|---|---|
| ICE | 100% | +3.90% | ||
| SPGI - ICE | 58% Loosely correlated | +2.24% | ||
| TW - ICE | 52% Loosely correlated | +1.57% | ||
| MCO - ICE | 51% Loosely correlated | +2.08% | ||
| TRU - ICE | 51% Loosely correlated | +5.74% | ||
| MSCI - ICE | 48% Loosely correlated | +2.61% | ||
More | ||||